Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. AstraZeneca CFO: 'We've come a long way in our oncology ...

    www.aol.com/finance/astrazeneca-cfo-weve-come...

    AstraZeneca has set a target to become an $80 billion company, in sales, by 2030. In 2023, the company booked $45.8 billion in revenue. CFO Aradhana Sarin said she is now focused on the execution ...

  3. AstraZeneca - Wikipedia

    en.wikipedia.org/wiki/AstraZeneca

    AstraZeneca plc ( / ˌæstrəˈzɛnəkə /) ( AZ) is a British-Swedish multinational pharmaceutical and biotechnology company [2] [3] [4] with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. [5] It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection ...

  4. Amgen - Wikipedia

    en.wikipedia.org/wiki/Amgen

    Amgen Inc. Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. [3] [4] One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total. [5] The name "AMGen" is a portmanteau of the ...

  5. AstraZeneca buys Canadian cancer treatment firm for ... - AOL

    www.aol.com/astrazeneca-buys-canadian-cancer...

    Susan Galbraith, AstraZeneca’s executive vice president of oncology R&D, said: “Between 30% and 50% of patients with cancer today receive radiotherapy at some point during treatment, and the ...

  6. Mene Pangalos - Wikipedia

    en.wikipedia.org/wiki/Mene_Pangalos

    Sir Menelaos (Mene) Nicolas Pangalos ( Greek: Μενέλαος Νικόλας Πάγκαλος) is a British neuroscientist of Greek descent. Pangalos is Executive Vice President, BioPharmaceuticals R&D at AstraZeneca. [1] He is responsible for the company's research and development of new drugs to treat respiratory, inflammation and autoimmune ...

  7. AstraZeneca's Imfinzi improves survival in late-stage lung ...

    www.aol.com/news/astrazenecas-imfinzi-shows...

    Imfinzi clocked $4.24 billion in sales in 2023, and is a blockbuster medicine in AstraZeneca's key oncology portfolio, which makes up more than 20% of its total revenues.

  8. AstraZeneca, AI biologics firm Absci tie up on cancer drug

    www.aol.com/news/astrazeneca-ai-biologics-firm...

    (Reuters) -Anglo-Swedish drugmaker AstraZeneca has signed a deal worth up to $247 million with U.S. artificial intelligence (AI) biologics firm Absci to design an antibody to fight cancer, Absci ...

  9. Paul Hudson (businessman) - Wikipedia

    en.wikipedia.org/wiki/Paul_Hudson_(businessman)

    Title. CEO, Sanofi. Term. September 2019-. Predecessor. Olivier Brandicourt. Children. 3. Paul Hudson (born 14 October 1967) [2] is a British businessman, and the chief executive (CEO) of Sanofi, the world's fifth largest pharmaceutical company by prescription drug sales.